HLA-C and breast carcinoma: Compared to whole-cell proteome derived neoantigens from canonical sequences, the numbers of MS/MS neoantigens in ncORFs was not significantly different (e.g. there were 31 mutation MHC-bound peptides in canonical sequences from the breast cancer cohort using the Comet search engine and a two-stage FDR strategy (30)).